nodes	percent_of_prediction	percent_of_DWPC	metapath
Digoxin—ABCB1—peripheral nervous system neoplasm	0.369	1	CbGaD
Digoxin—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0981	0.248	CbGbCtD
Digoxin—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0613	0.155	CbGbCtD
Digoxin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0394	0.0997	CbGbCtD
Digoxin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0394	0.0997	CbGbCtD
Digoxin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0273	0.0691	CbGbCtD
Digoxin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0236	0.0597	CbGbCtD
Digoxin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0219	0.0555	CbGbCtD
Digoxin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0168	0.0426	CbGbCtD
Digoxin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0157	0.0397	CbGbCtD
Digoxin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0154	0.039	CbGbCtD
Digoxin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0105	0.0266	CbGbCtD
Digoxin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0101	0.0255	CbGbCtD
Digoxin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00923	0.0234	CbGbCtD
Digoxin—SLC51A—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00645	0.101	CbGpPWpGaD
Digoxin—SLC51B—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00645	0.101	CbGpPWpGaD
Digoxin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0063	0.0159	CbGbCtD
Digoxin—ATP1A2—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.00619	0.0971	CbGpPWpGaD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00298	0.0467	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00256	0.0402	CbGpPWpGaD
Digoxin—SLCO1C1—ganglion—peripheral nervous system neoplasm	0.00235	0.0867	CbGeAlD
Digoxin—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.00178	0.013	CcSEcCtD
Digoxin—ATP1A3—trigeminal ganglion—peripheral nervous system neoplasm	0.00177	0.0656	CbGeAlD
Digoxin—ATP1B1—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00177	0.249	CbGdCrCtD
Digoxin—ATP1A3—brainstem—peripheral nervous system neoplasm	0.00157	0.058	CbGeAlD
Digoxin—Rash maculo-papular—Topotecan—peripheral nervous system neoplasm	0.00157	0.0114	CcSEcCtD
Digoxin—Rash maculo-papular—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.0113	CcSEcCtD
Digoxin—Rash maculo-papular—Tretinoin—peripheral nervous system neoplasm	0.00155	0.0113	CcSEcCtD
Digoxin—ATP1B3—brainstem—peripheral nervous system neoplasm	0.00147	0.0542	CbGeAlD
Digoxin—SLCO2B1—ganglion—peripheral nervous system neoplasm	0.00146	0.0541	CbGeAlD
Digoxin—ATP1B2—trigeminal ganglion—peripheral nervous system neoplasm	0.00145	0.0535	CbGeAlD
Digoxin—ATP1A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00141	0.0521	CbGeAlD
Digoxin—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00141	0.0103	CcSEcCtD
Digoxin—Drug interaction—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.0102	CcSEcCtD
Digoxin—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00139	0.0218	CbGpPWpGaD
Digoxin—SLCO4C1—parotid gland—peripheral nervous system neoplasm	0.00136	0.0504	CbGeAlD
Digoxin—Drug interaction—Vincristine—peripheral nervous system neoplasm	0.00135	0.00982	CcSEcCtD
Digoxin—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00955	CcSEcCtD
Digoxin—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00955	CcSEcCtD
Digoxin—Necrosis—Etoposide—peripheral nervous system neoplasm	0.00129	0.0094	CcSEcCtD
Digoxin—ATP1B2—brainstem—peripheral nervous system neoplasm	0.00128	0.0473	CbGeAlD
Digoxin—ATP1A2—brainstem—peripheral nervous system neoplasm	0.00125	0.0461	CbGeAlD
Digoxin—ATP1B1—trigeminal ganglion—peripheral nervous system neoplasm	0.00123	0.0453	CbGeAlD
Digoxin—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00884	CcSEcCtD
Digoxin—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00884	CcSEcCtD
Digoxin—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00119	0.00868	CcSEcCtD
Digoxin—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00861	CcSEcCtD
Digoxin—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00861	CcSEcCtD
Digoxin—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00118	0.0185	CbGpPWpGaD
Digoxin—Rash maculo-papular—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00859	CcSEcCtD
Digoxin—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00117	0.0085	CcSEcCtD
Digoxin—ATP1B1—parotid gland—peripheral nervous system neoplasm	0.00116	0.0427	CbGeAlD
Digoxin—ATP1B1—brainstem—peripheral nervous system neoplasm	0.00109	0.0401	CbGeAlD
Digoxin—ABCB11—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00107	0.0167	CbGpPWpGaD
Digoxin—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.000993	0.00724	CcSEcCtD
Digoxin—SLCO4A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000924	0.0341	CbGeAlD
Digoxin—ATP1B1—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000923	0.13	CbGdCrCtD
Digoxin—ATP1B1—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000923	0.13	CbGdCrCtD
Digoxin—ATP1B1—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000923	0.13	CbGdCrCtD
Digoxin—Rash maculo-papular—Etoposide—peripheral nervous system neoplasm	0.00092	0.00671	CcSEcCtD
Digoxin—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.000919	0.0067	CcSEcCtD
Digoxin—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.000895	0.00652	CcSEcCtD
Digoxin—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000862	0.00629	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000857	0.0134	CbGpPWpGaD
Digoxin—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.000855	0.00623	CcSEcCtD
Digoxin—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.000855	0.00623	CcSEcCtD
Digoxin—ATP1B1—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.12	CbGdCrCtD
Digoxin—ATP1B1—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.12	CbGdCrCtD
Digoxin—ATP1B1—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.12	CbGdCrCtD
Digoxin—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.000828	0.00604	CcSEcCtD
Digoxin—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.000828	0.00604	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000785	0.0123	CbGpPWpGaD
Digoxin—ATP1A3—cerebellum—peripheral nervous system neoplasm	0.000774	0.0286	CbGeAlD
Digoxin—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000767	0.0056	CcSEcCtD
Digoxin—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000767	0.0056	CcSEcCtD
Digoxin—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000766	0.00559	CcSEcCtD
Digoxin—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000761	0.0119	CbGpPWpGaD
Digoxin—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000757	0.00552	CcSEcCtD
Digoxin—ATP1B3—cerebellum—peripheral nervous system neoplasm	0.000723	0.0267	CbGeAlD
Digoxin—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.000723	0.00527	CcSEcCtD
Digoxin—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000709	0.00517	CcSEcCtD
Digoxin—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.000705	0.00514	CcSEcCtD
Digoxin—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.000705	0.00514	CcSEcCtD
Digoxin—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000698	0.00509	CcSEcCtD
Digoxin—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.00488	CcSEcCtD
Digoxin—ATP1A4—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000665	0.0104	CbGpPWpGaD
Digoxin—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000661	0.00482	CcSEcCtD
Digoxin—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000661	0.00482	CcSEcCtD
Digoxin—Delirium—Epirubicin—peripheral nervous system neoplasm	0.000659	0.00481	CcSEcCtD
Digoxin—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000648	0.00472	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000639	0.01	CbGpPWpGaD
Digoxin—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000634	0.00463	CcSEcCtD
Digoxin—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000634	0.00463	CcSEcCtD
Digoxin—ATP1A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000634	0.0234	CbGeAlD
Digoxin—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	0.000632	0.0233	CbGeAlD
Digoxin—ATP1B2—cerebellum—peripheral nervous system neoplasm	0.000631	0.0233	CbGeAlD
Digoxin—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00458	CcSEcCtD
Digoxin—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.000627	0.00457	CcSEcCtD
Digoxin—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000624	0.00455	CcSEcCtD
Digoxin—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000615	0.00449	CcSEcCtD
Digoxin—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000615	0.00449	CcSEcCtD
Digoxin—ATP1A2—cerebellum—peripheral nervous system neoplasm	0.000615	0.0227	CbGeAlD
Digoxin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000612	0.0096	CbGpPWpGaD
Digoxin—Delirium—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00445	CcSEcCtD
Digoxin—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000602	0.00439	CcSEcCtD
Digoxin—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000598	0.00436	CcSEcCtD
Digoxin—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000598	0.00436	CcSEcCtD
Digoxin—ATP1A1—parotid gland—peripheral nervous system neoplasm	0.000598	0.0221	CbGeAlD
Digoxin—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000596	0.00434	CcSEcCtD
Digoxin—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000596	0.00434	CcSEcCtD
Digoxin—FXYD2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000593	0.00929	CbGpPWpGaD
Digoxin—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00059	0.0043	CcSEcCtD
Digoxin—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000588	0.00429	CcSEcCtD
Digoxin—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000586	0.00428	CcSEcCtD
Digoxin—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00426	CcSEcCtD
Digoxin—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000582	0.00425	CcSEcCtD
Digoxin—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000582	0.00424	CcSEcCtD
Digoxin—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000582	0.00424	CcSEcCtD
Digoxin—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00424	CcSEcCtD
Digoxin—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00424	CcSEcCtD
Digoxin—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000574	0.00419	CcSEcCtD
Digoxin—Ventricular tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000567	0.00414	CcSEcCtD
Digoxin—ATP1A1—brainstem—peripheral nervous system neoplasm	0.000561	0.0207	CbGeAlD
Digoxin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000542	0.00395	CcSEcCtD
Digoxin—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00395	CcSEcCtD
Digoxin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000537	0.00392	CcSEcCtD
Digoxin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000537	0.00392	CcSEcCtD
Digoxin—Digitoxin—ABCB1—peripheral nervous system neoplasm	0.000536	1	CrCbGaD
Digoxin—ATP1B1—cerebellum—peripheral nervous system neoplasm	0.000535	0.0198	CbGeAlD
Digoxin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000535	0.0039	CcSEcCtD
Digoxin—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000535	0.0039	CcSEcCtD
Digoxin—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.00389	CcSEcCtD
Digoxin—ATP1B1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000531	0.00833	CbGpPWpGaD
Digoxin—ATP1B2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000531	0.00833	CbGpPWpGaD
Digoxin—ATP1B3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000531	0.00833	CbGpPWpGaD
Digoxin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000531	0.00387	CcSEcCtD
Digoxin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00053	0.00387	CcSEcCtD
Digoxin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00053	0.00387	CcSEcCtD
Digoxin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00053	0.00387	CcSEcCtD
Digoxin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000527	0.00384	CcSEcCtD
Digoxin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000527	0.00384	CcSEcCtD
Digoxin—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.00383	CcSEcCtD
Digoxin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000524	0.00382	CcSEcCtD
Digoxin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00052	0.00379	CcSEcCtD
Digoxin—Rash maculo-papular—Epirubicin—peripheral nervous system neoplasm	0.000516	0.00376	CcSEcCtD
Digoxin—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000515	0.00375	CcSEcCtD
Digoxin—ATP1B1—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000512	0.00803	CbGpPWpGaD
Digoxin—ATP1B3—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000512	0.00803	CbGpPWpGaD
Digoxin—ATP1B2—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000512	0.00803	CbGpPWpGaD
Digoxin—ATP1A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000508	0.00797	CbGpPWpGaD
Digoxin—ATP1A4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000508	0.00797	CbGpPWpGaD
Digoxin—ATP1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000508	0.00797	CbGpPWpGaD
Digoxin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000507	0.0037	CcSEcCtD
Digoxin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000503	0.00367	CcSEcCtD
Digoxin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00367	CcSEcCtD
Digoxin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00367	CcSEcCtD
Digoxin—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00365	CcSEcCtD
Digoxin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000499	0.00364	CcSEcCtD
Digoxin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000499	0.00364	CcSEcCtD
Digoxin—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000495	0.00361	CcSEcCtD
Digoxin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.00356	CcSEcCtD
Digoxin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000486	0.00355	CcSEcCtD
Digoxin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00352	CcSEcCtD
Digoxin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00352	CcSEcCtD
Digoxin—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.00351	CcSEcCtD
Digoxin—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.00348	CcSEcCtD
Digoxin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000475	0.00347	CcSEcCtD
Digoxin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000472	0.00344	CcSEcCtD
Digoxin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.0034	CcSEcCtD
Digoxin—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00332	CcSEcCtD
Digoxin—FXYD2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000453	0.0071	CbGpPWpGaD
Digoxin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.0033	CcSEcCtD
Digoxin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00329	CcSEcCtD
Digoxin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000441	0.00322	CcSEcCtD
Digoxin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.00321	CcSEcCtD
Digoxin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00319	CcSEcCtD
Digoxin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00319	CcSEcCtD
Digoxin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000436	0.00318	CcSEcCtD
Digoxin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.00316	CcSEcCtD
Digoxin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000432	0.00315	CcSEcCtD
Digoxin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000429	0.00673	CbGpPWpGaD
Digoxin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000425	0.0031	CcSEcCtD
Digoxin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000421	0.00307	CcSEcCtD
Digoxin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000418	0.00304	CcSEcCtD
Digoxin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000418	0.00304	CcSEcCtD
Digoxin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000412	0.00301	CcSEcCtD
Digoxin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.003	CcSEcCtD
Digoxin—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00299	CcSEcCtD
Digoxin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000408	0.00297	CcSEcCtD
Digoxin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00297	CcSEcCtD
Digoxin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000407	0.00297	CcSEcCtD
Digoxin—ATP1B2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000406	0.00637	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000406	0.00637	CbGpPWpGaD
Digoxin—ATP1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000406	0.00637	CbGpPWpGaD
Digoxin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.00294	CcSEcCtD
Digoxin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000404	0.00294	CcSEcCtD
Digoxin—SLCO4A1—cerebellum—peripheral nervous system neoplasm	0.000403	0.0149	CbGeAlD
Digoxin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000402	0.00293	CcSEcCtD
Digoxin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00291	CcSEcCtD
Digoxin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000394	0.00288	CcSEcCtD
Digoxin—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000392	0.00285	CcSEcCtD
Digoxin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000391	0.00285	CcSEcCtD
Digoxin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000388	0.00283	CcSEcCtD
Digoxin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000388	0.00283	CcSEcCtD
Digoxin—Rash—Topotecan—peripheral nervous system neoplasm	0.000388	0.00283	CcSEcCtD
Digoxin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000388	0.00283	CcSEcCtD
Digoxin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000387	0.00282	CcSEcCtD
Digoxin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00281	CcSEcCtD
Digoxin—Headache—Topotecan—peripheral nervous system neoplasm	0.000385	0.00281	CcSEcCtD
Digoxin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00281	CcSEcCtD
Digoxin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00281	CcSEcCtD
Digoxin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000385	0.00281	CcSEcCtD
Digoxin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000385	0.0028	CcSEcCtD
Digoxin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000384	0.0028	CcSEcCtD
Digoxin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000384	0.0028	CcSEcCtD
Digoxin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000383	0.00279	CcSEcCtD
Digoxin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000382	0.00279	CcSEcCtD
Digoxin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000382	0.00279	CcSEcCtD
Digoxin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00278	CcSEcCtD
Digoxin—Rash—Melphalan—peripheral nervous system neoplasm	0.00038	0.00277	CcSEcCtD
Digoxin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000379	0.00277	CcSEcCtD
Digoxin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00276	CcSEcCtD
Digoxin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000376	0.00274	CcSEcCtD
Digoxin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00267	CcSEcCtD
Digoxin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000365	0.00266	CcSEcCtD
Digoxin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000364	0.00266	CcSEcCtD
Digoxin—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000364	0.00571	CbGpPWpGaD
Digoxin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000364	0.00265	CcSEcCtD
Digoxin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000362	0.00264	CcSEcCtD
Digoxin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000362	0.00264	CcSEcCtD
Digoxin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00264	CcSEcCtD
Digoxin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00261	CcSEcCtD
Digoxin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000358	0.00261	CcSEcCtD
Digoxin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000353	0.00258	CcSEcCtD
Digoxin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000352	0.00257	CcSEcCtD
Digoxin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000352	0.00257	CcSEcCtD
Digoxin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000344	0.00251	CcSEcCtD
Digoxin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000343	0.0025	CcSEcCtD
Digoxin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000341	0.00249	CcSEcCtD
Digoxin—SLCO4C1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000341	0.00535	CbGpPWpGaD
Digoxin—SLCO4A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000341	0.00535	CbGpPWpGaD
Digoxin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00034	0.00248	CcSEcCtD
Digoxin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00242	CcSEcCtD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000328	0.00513	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000328	0.00513	CbGpPWpGaD
Digoxin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00237	CcSEcCtD
Digoxin—CYP11A1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000321	0.00503	CbGpPWpGaD
Digoxin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00032	0.00233	CcSEcCtD
Digoxin—ATP1A3—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000319	0.00501	CbGpPWpGaD
Digoxin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.00231	CcSEcCtD
Digoxin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00231	CcSEcCtD
Digoxin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.00229	CcSEcCtD
Digoxin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000314	0.00229	CcSEcCtD
Digoxin—SLCO2B1—cerebellum—peripheral nervous system neoplasm	0.000314	0.0116	CbGeAlD
Digoxin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000312	0.00227	CcSEcCtD
Digoxin—ATP1B2—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000308	0.00483	CbGpPWpGaD
Digoxin—ATP1B1—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000308	0.00483	CbGpPWpGaD
Digoxin—ATP1B3—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000308	0.00483	CbGpPWpGaD
Digoxin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00223	CcSEcCtD
Digoxin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000305	0.00222	CcSEcCtD
Digoxin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000297	0.00217	CcSEcCtD
Digoxin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000296	0.00216	CcSEcCtD
Digoxin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000295	0.00215	CcSEcCtD
Digoxin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000295	0.00215	CcSEcCtD
Digoxin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00214	CcSEcCtD
Digoxin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00213	CcSEcCtD
Digoxin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00212	CcSEcCtD
Digoxin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00211	CcSEcCtD
Digoxin—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.000289	0.0107	CbGeAlD
Digoxin—SLCO1C1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000286	0.00448	CbGpPWpGaD
Digoxin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000285	0.00208	CcSEcCtD
Digoxin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000283	0.00207	CcSEcCtD
Digoxin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00206	CcSEcCtD
Digoxin—Rash—Vincristine—peripheral nervous system neoplasm	0.000281	0.00205	CcSEcCtD
Digoxin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000281	0.00205	CcSEcCtD
Digoxin—Headache—Vincristine—peripheral nervous system neoplasm	0.000279	0.00204	CcSEcCtD
Digoxin—ATP1A1—cerebellum—peripheral nervous system neoplasm	0.000276	0.0102	CbGeAlD
Digoxin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.002	CcSEcCtD
Digoxin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000274	0.002	CcSEcCtD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000274	0.0043	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000274	0.0043	CbGpPWpGaD
Digoxin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00027	0.00197	CcSEcCtD
Digoxin—ATP1A4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000269	0.00422	CbGpPWpGaD
Digoxin—ATP1A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000269	0.00422	CbGpPWpGaD
Digoxin—ATP1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000269	0.00422	CbGpPWpGaD
Digoxin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000265	0.00193	CcSEcCtD
Digoxin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00193	CcSEcCtD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000263	0.00412	CbGpPWpGaD
Digoxin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000259	0.00189	CcSEcCtD
Digoxin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00186	CcSEcCtD
Digoxin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00185	CcSEcCtD
Digoxin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00183	CcSEcCtD
Digoxin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00181	CcSEcCtD
Digoxin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00181	CcSEcCtD
Digoxin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000247	0.0018	CcSEcCtD
Digoxin—ATP1B3—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000247	0.00387	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000247	0.00387	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000247	0.00387	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000245	0.00384	CbGpPWpGaD
Digoxin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00178	CcSEcCtD
Digoxin—FXYD2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00024	0.00376	CbGpPWpGaD
Digoxin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000239	0.00174	CcSEcCtD
Digoxin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00172	CcSEcCtD
Digoxin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000235	0.00368	CbGpPWpGaD
Digoxin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000234	0.00171	CcSEcCtD
Digoxin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000234	0.0017	CcSEcCtD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000231	0.00362	CbGpPWpGaD
Digoxin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00023	0.00167	CcSEcCtD
Digoxin—ATP1B3—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000229	0.00358	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000229	0.00358	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000229	0.00358	CbGpPWpGaD
Digoxin—Rash—Etoposide—peripheral nervous system neoplasm	0.000228	0.00166	CcSEcCtD
Digoxin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000227	0.00166	CcSEcCtD
Digoxin—Headache—Etoposide—peripheral nervous system neoplasm	0.000226	0.00165	CcSEcCtD
Digoxin—ATP1B2—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000225	0.00353	CbGpPWpGaD
Digoxin—ATP1B3—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000225	0.00353	CbGpPWpGaD
Digoxin—ATP1B1—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000225	0.00353	CbGpPWpGaD
Digoxin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000222	0.00819	CbGeAlD
Digoxin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000219	0.0016	CcSEcCtD
Digoxin—ATP1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000216	0.00339	CbGpPWpGaD
Digoxin—ATP1A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000216	0.00339	CbGpPWpGaD
Digoxin—ATP1A4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000216	0.00339	CbGpPWpGaD
Digoxin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00158	CcSEcCtD
Digoxin—ATP1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000215	0.00337	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000215	0.00337	CbGpPWpGaD
Digoxin—ATP1B2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000215	0.00337	CbGpPWpGaD
Digoxin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000214	0.00156	CcSEcCtD
Digoxin—ATP1A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000212	0.00333	CbGpPWpGaD
Digoxin—ATP1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000212	0.00333	CbGpPWpGaD
Digoxin—ATP1A4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000212	0.00333	CbGpPWpGaD
Digoxin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00153	CcSEcCtD
Digoxin—SLCO2B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000207	0.00325	CbGpPWpGaD
Digoxin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00149	CcSEcCtD
Digoxin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00148	CcSEcCtD
Digoxin—ATP1B2—Hemostasis—GNAS—peripheral nervous system neoplasm	0.0002	0.00313	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—GNAS—peripheral nervous system neoplasm	0.0002	0.00313	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—GNAS—peripheral nervous system neoplasm	0.0002	0.00313	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000199	0.00312	CbGpPWpGaD
Digoxin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00144	CcSEcCtD
Digoxin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00144	CcSEcCtD
Digoxin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00142	CcSEcCtD
Digoxin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00141	CcSEcCtD
Digoxin—FXYD2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000193	0.00302	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000193	0.00302	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—HGF—peripheral nervous system neoplasm	0.00019	0.00298	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—HGF—peripheral nervous system neoplasm	0.00019	0.00298	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—HGF—peripheral nervous system neoplasm	0.00019	0.00298	CbGpPWpGaD
Digoxin—FXYD2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000189	0.00297	CbGpPWpGaD
Digoxin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00138	CcSEcCtD
Digoxin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00134	CcSEcCtD
Digoxin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00133	CcSEcCtD
Digoxin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.0013	CcSEcCtD
Digoxin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.0013	CcSEcCtD
Digoxin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00128	CcSEcCtD
Digoxin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00127	CcSEcCtD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000173	0.00272	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000173	0.00272	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000173	0.00271	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000173	0.00271	CbGpPWpGaD
Digoxin—ATP1B2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000173	0.00271	CbGpPWpGaD
Digoxin—ATP1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000173	0.00271	CbGpPWpGaD
Digoxin—ATP1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00017	0.00266	CbGpPWpGaD
Digoxin—ATP1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00017	0.00266	CbGpPWpGaD
Digoxin—ATP1B2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00017	0.00266	CbGpPWpGaD
Digoxin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00122	CcSEcCtD
Digoxin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00121	CcSEcCtD
Digoxin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.0012	CcSEcCtD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000165	0.00258	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000163	0.00256	CbGpPWpGaD
Digoxin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00119	CcSEcCtD
Digoxin—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000162	0.00254	CbGpPWpGaD
Digoxin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00118	CcSEcCtD
Digoxin—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000162	0.00253	CbGpPWpGaD
Digoxin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00117	CcSEcCtD
Digoxin—CYP11A1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.00016	0.00251	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000155	0.00244	CbGpPWpGaD
Digoxin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00113	CcSEcCtD
Digoxin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00112	CcSEcCtD
Digoxin—ABCB11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000152	0.00238	CbGpPWpGaD
Digoxin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00108	CcSEcCtD
Digoxin—ATP1A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000145	0.00228	CbGpPWpGaD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000145	0.00228	CbGpPWpGaD
Digoxin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00106	CcSEcCtD
Digoxin—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000143	0.00225	CbGpPWpGaD
Digoxin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000142	0.00222	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000139	0.00219	CbGpPWpGaD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000139	0.00219	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000139	0.00218	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000139	0.00218	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000139	0.00218	CbGpPWpGaD
Digoxin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00101	CcSEcCtD
Digoxin—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000138	0.00216	CbGpPWpGaD
Digoxin—SLCO4A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000137	0.00215	CbGpPWpGaD
Digoxin—SLCO4C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000137	0.00215	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000137	0.00214	CbGpPWpGaD
Digoxin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000135	0.00211	CbGpPWpGaD
Digoxin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00098	CcSEcCtD
Digoxin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000976	CcSEcCtD
Digoxin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000938	CcSEcCtD
Digoxin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000934	CcSEcCtD
Digoxin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00093	CcSEcCtD
Digoxin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00093	CcSEcCtD
Digoxin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000127	0.00199	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000127	0.00199	CbGpPWpGaD
Digoxin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000924	CcSEcCtD
Digoxin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000903	CcSEcCtD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000122	0.00191	CbGpPWpGaD
Digoxin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000876	CcSEcCtD
Digoxin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000868	CcSEcCtD
Digoxin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000861	CcSEcCtD
Digoxin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00086	CcSEcCtD
Digoxin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000855	CcSEcCtD
Digoxin—CYP11A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000117	0.00183	CbGpPWpGaD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000117	0.00183	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000117	0.00183	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000115	0.0018	CbGpPWpGaD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000115	0.0018	CbGpPWpGaD
Digoxin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000811	CcSEcCtD
Digoxin—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000109	0.00171	CbGpPWpGaD
Digoxin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000109	0.00171	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000109	0.0017	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000105	0.00165	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000104	0.00164	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000103	0.00161	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.72e-05	0.00152	CbGpPWpGaD
Digoxin—ABCB1—cerebellum—peripheral nervous system neoplasm	9.67e-05	0.00357	CbGeAlD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.07e-05	0.00142	CbGpPWpGaD
Digoxin—CYP11A1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	8.65e-05	0.00136	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.57e-05	0.00134	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.53e-05	0.00134	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.48e-05	0.00133	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GNS—peripheral nervous system neoplasm	8.46e-05	0.00133	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—NRAS—peripheral nervous system neoplasm	8.35e-05	0.00131	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—NRAS—peripheral nervous system neoplasm	8.35e-05	0.00131	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—NRAS—peripheral nervous system neoplasm	8.35e-05	0.00131	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.32e-05	0.0013	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.23e-05	0.00129	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—NME1—peripheral nervous system neoplasm	8.11e-05	0.00127	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	7.89e-05	0.00124	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—COX2—peripheral nervous system neoplasm	7.8e-05	0.00122	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	7.56e-05	0.00119	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	7.42e-05	0.00116	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.33e-05	0.00115	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	7.28e-05	0.00114	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.28e-05	0.00114	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.13e-05	0.00112	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	7.12e-05	0.00112	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	6.85e-05	0.00107	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6.7e-05	0.00105	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.62e-05	0.00104	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.49e-05	0.00102	CbGpPWpGaD
Digoxin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.48e-05	0.00102	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.46e-05	0.00101	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—TP53—peripheral nervous system neoplasm	6.39e-05	0.001	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—TP53—peripheral nervous system neoplasm	6.39e-05	0.001	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—TP53—peripheral nervous system neoplasm	6.39e-05	0.001	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	6.2e-05	0.000972	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.11e-05	0.000958	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—HRAS—peripheral nervous system neoplasm	6.11e-05	0.000958	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—HRAS—peripheral nervous system neoplasm	6.11e-05	0.000958	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—HRAS—peripheral nervous system neoplasm	6.11e-05	0.000958	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.09e-05	0.000955	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	5.94e-05	0.000932	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.86e-05	0.000918	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.75e-05	0.000901	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	5.72e-05	0.000897	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	5.66e-05	0.000888	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.59e-05	0.000877	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.53e-05	0.000866	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.43e-05	0.000852	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000846	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000846	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000846	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	5.3e-05	0.000831	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.23e-05	0.00082	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.2e-05	0.000815	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—ENO2—peripheral nervous system neoplasm	5.12e-05	0.000803	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.1e-05	0.0008	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	5.08e-05	0.000797	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	4.89e-05	0.000767	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	4.78e-05	0.000749	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	4.5e-05	0.000705	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.45e-05	0.000697	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.36e-05	0.000684	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—BCHE—peripheral nervous system neoplasm	4.33e-05	0.000679	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.13e-05	0.000647	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—TH—peripheral nervous system neoplasm	4.07e-05	0.000638	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	4.04e-05	0.000633	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.85e-05	0.000604	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	3.8e-05	0.000596	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	3.8e-05	0.000595	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.76e-05	0.000589	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.67e-05	0.000575	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.63e-05	0.000568	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	3.57e-05	0.00056	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.54e-05	0.000555	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.35e-05	0.000525	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.32e-05	0.000521	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.26e-05	0.000511	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.21e-05	0.000503	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.17e-05	0.000497	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	3.1e-05	0.000486	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.08e-05	0.000483	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.04e-05	0.000477	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.03e-05	0.000475	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	2.98e-05	0.000468	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	2.92e-05	0.000457	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	2.86e-05	0.000449	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.79e-05	0.000438	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.77e-05	0.000434	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	2.71e-05	0.000425	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.65e-05	0.000416	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.59e-05	0.000406	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	2.55e-05	0.0004	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.54e-05	0.000399	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.45e-05	0.000384	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.44e-05	0.000382	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.39e-05	0.000375	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.26e-05	0.000354	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.23e-05	0.000349	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.18e-05	0.000342	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.08e-05	0.000327	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.04e-05	0.00032	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.79e-05	0.000281	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.63e-05	0.000256	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.61e-05	0.000252	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.57e-05	0.000246	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000237	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.51e-05	0.000237	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.36e-05	0.000213	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.3e-05	0.000203	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.28e-05	0.0002	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000163	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	9.9e-06	0.000155	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—AKT1—peripheral nervous system neoplasm	8.97e-06	0.000141	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	8.37e-06	0.000131	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	8.37e-06	0.000131	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.98e-06	0.000125	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	7.87e-06	0.000123	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.87e-06	0.000123	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	6.57e-06	0.000103	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	6.42e-06	0.000101	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.3e-06	9.88e-05	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	5.62e-06	8.81e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.81e-06	4.41e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-06	2.72e-05	CbGpPWpGaD
